top of page
IMG_7352.JPG
new 珞米logo_转曲.png

Nanomics Autolab
Large-Scale Proteomics Made Easy

Autolab offers seamless, high-throughput proteomics service for large-cohort studies.

 

We make it easy to get accurate, consistent data on a large scale, supporting everything from biomarker discovery to disease research.

 

Our automated platform is designed to handle big studies efficiently, so you get reliable insights faster.

Plasma Proteomics
​10 x deeper       10 x faster

Reliable Data Quality

Precision and consistency for dependable results.

Scalable Automation

Handles pretomics studies of any size, big or small.

Cost-Effective

Affordable solution for large-scale studies without compromising quality.

High Throughput

Fast processing for large sample volumes.

How we ensure data quality?

Proteonano™
quality control system

In large cohort proteomics experiments with mass spec, subgroups of protein measurements with quantitatively different behaviors (i.e. batch effect) oftentimes hinders the downstream bioinformatic analysis.

Nanomics’ s Proteonano™ Ultraplex proteomics platform features a built-in quality control system (QCS), enabling comprehensive monitoring at the individual sample level.

 

Here’s how it works:

截屏2024-11-11 16.10.19.png
Step 1: Incubation controls

 Recommended sample quality control solution

QC 1: QC1 is made up of pooled healthy human plasma samples to monitor the protein enrichment process (Step 1: Incubation controls) and correct potential inter-plate variations. Typically, three replicates of QC1 are included in each fully loaded 96-well plate.

QC 2: QC2 is also pooled healthy human plasma but remains untreated by the Proteonano™ Plasma Kit (i.e., neat plasma).

图片 1.png

 QC 3: QC3 is a lyophilized peptide mix derived from pooled healthy human plasma that has undergone enrichment, reduction, alkylation, enzymatic digestion, and desalting. 

Step 2: Detection controls

LC-MS/MS status check prior experiments: 

 

To evaluate the overall performance of the LC-MS/MS, we use QC 3 samples. These samples undergo the same procedures as the actual experimental samples, focusing on assessing the performance of the LC-MS/MS. Typically, a QC 3 sample is run every 10-20 LC-MS/MS runs.

 

The quality control workflow for LC-MS/MS experiments is shown in Figure 4.

LC-MS/MS status check prior experiments
Step 3: Data analysis controls
Batch effect correction:
 

Batch effects can arise from differences in sample preparation, data acquisition conditions, and variations in technicians, reagent quality, and various instruments. These factors reduce the ability to detect genuine biological signals.

 

The Proteonano™ platform features an integrated data analysis workflow that ensures consistency of QC samples across multiple batches. It achieves a median interplate %CV of below 20% and an median intraplate %CV of below 15%.

截屏2024-11-07 13.29_edited.png
截屏2024-11-11 16.55.20.png
Case study:
Use the Proteonano platform to conduct a cohort with 540 plasma samples

Here’ s an example of how to quickly and robustly conduct a proteomics cohort study using the Proteonano™ platform with a cohort of 540 plasma samples.

Stability of protein identification and inter-batch correlation for QC samples

 

We assessed the stability of protein enrichment using QC1 samples across 6 batches (a total of 18 QC1 samples). As shown in Figure 6, the median CV for protein quantity between batches is below 10%, and the median CV for protein intensity quantification is below 15%. This demonstrates the stability of protein enrichment across different batches in the project.

PGs identified for QC1 samples across 6 batches

Figure 6: PGs identified for QC1 samples across 6 batches

We also assessed the pairwise correlations of the 18 QC1 samples throughout the project to ensure that Pearson correlation coefficients exceed 90% both between and within batches.

截屏2024-11-12 10.35.34.png

Figure 7: Pearson correlation across 18 QC1 samples from 6 batches

We will empower you to
discover protein biomarkers
and drive them through every step
to real-world applications

Step 3:
Translation
Step 2:
Validation
标志物发现.png
Step 1:
Discover
clinically validated biomarkers

“At Nanomics Autolab Center of Excellences, we are dedicated to providing the best services to accelerate mass spec-based large cohort clinical proteomics studies with excellent robustness, high-throughput, and cost-effectiveness.“

- Dr. Hao Wu, Founder & CEO of Nanomics

资源 3@4x-8.png

Ready to analyze? Get started here

Let’s talk about your project and see how our lab can help drive your research and support your diagnostic goals.

Thanks for submitting!

Nanomics Biotechnology, Inc.

1724 East 54th Street, Chicago, IL 60615, USA

+86 19357321977

bd@nanomics.bio

Follow Us On:

  • Linkedin

© 2035 by Vista.io. Powered and secured by Wix

bottom of page